Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Sarcoma 7Ovarian Neoplasms 5Liposarcoma 2Leiomyosarcoma 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Carboplatin 8Paclitaxel 7Hyperthermic Intraperitoneal Chemotherapy 7Bevacizumab 4liposomal doxorubicin 3Gemcitabine 3Oxaliplatin 2Neoadjuvant Therapy 2relacorilant 1phenoxodiol 1pembrolizumab 1oregovomab 1olaparib 1nintedanib 1lobaplatin 1lanreotide 1epothilone B 1atezolizumab 1Trabectedin 1Topotecan 1Therapeutics 1Surgical Procedures, Operative 1Saline Solution 1Leucovorin 1Letrozole 1Laparotomy 1Laparoscopy 1LAIF 900 1Hypericum extract LI 160 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Peritoneal Neoplasms × Trabectedin × Clear all
NCT01846611 2019-04-01

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Janssen Research & Development, LLC

Phase 3 Completed
581 enrolled 14 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡